Blue Chip Partners, LLC / ABBV
Blue Chip Partners, LLC’s Abbvie Inc Position
Does Blue Chip Partners, LLC own Abbvie Inc (ABBV)? Yes — 191.4K shares worth $42M (+3.00% of its 13F portfolio) as of Q1 2026, up from 189.8K shares the prior filed quarter.
Position Value
$42M
Q1 2026
Shares
191.4K
% of Portfolio
+3.00%
Quarters Held
30
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 191.4K | $42M | +3.00% |
| Q4 2025 | 189.8K | $43M | +3.14% |
| Q3 2025 | 189.0K | $44M | +3.27% |
| Q2 2025 | 188.3K | $35M | +2.85% |
| Q1 2025 | 185.3K | $39M | +3.35% |
| Q4 2024 | 182.9K | $33M | +2.79% |
| Q3 2024 | 181.3K | $36M | +3.11% |
| Q2 2024 | 182.5K | $31M | +2.89% |
| Q1 2024 | 177.2K | $32M | +3.13% |
| Q4 2023 | 179.4K | $28M | +2.90% |
| Q3 2023 | 177.1K | $26M | +3.15% |
| Q2 2023 | 172.7K | $23M | +2.64% |
| Q1 2023 | 173.7K | $28M | +3.28% |
| Q4 2022 | 176.4K | $29M | +3.55% |
| Q3 2022 | 191.0K | $26M | +3.51% |
| Q2 2022 | 185.9K | $28M | +3.63% |
| Q1 2022 | 183.4K | $30M | +3.70% |
| Q4 2021 | 182.5K | $25M | +3.10% |
| Q3 2021 | 177.3K | $19M | +2.69% |
| Q2 2021 | 173.8K | $20M | +2.79% |
| Q1 2021 | 169.5K | $18M | +2.82% |
| Q4 2020 | 175.5K | $19M | +2.94% |
| Q3 2020 | 167.7K | $15M | +2.61% |
| Q2 2020 | 163.9K | $16M | +3.15% |
| Q1 2020 | 156.4K | $12M | +2.96% |
| Q4 2019 | 160.9K | $14M | +2.71% |
| Q3 2019 | 147.9K | $11M | +2.37% |
| Q2 2019 | 133.6K | $10M | +2.18% |
| Q1 2019 | 123.5K | $10M | +2.36% |
| Q4 2018 | 111.3K | $10M | +2.58% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Blue Chip Partners, LLC’s full portfolio or all institutional holders of ABBV.